Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Creams: SOP for Inline Particle Size Monitoring – V 2.0

Posted on By

Creams: SOP for Inline Particle Size Monitoring – V 2.0

Standard Operating Procedure for Inline Particle Size Monitoring

Department Creams
SOP No. SOP/CRM/168/2025
Supersedes SOP/CRM/168/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to outline the procedure for inline particle size monitoring during the manufacturing of cream products. Particle size plays a key role in determining the texture, stability, and overall quality of the final product. This SOP ensures that the particle size is continuously monitored in real-time to maintain product consistency.

2. Scope

This SOP applies to the process of inline particle size monitoring during cream manufacturing. It covers the installation, operation, and maintenance of inline particle size monitoring equipment to ensure the cream formulation meets the desired specifications.

3. Responsibilities

  • Production Team: Responsible for operating the inline particle size monitoring system during the production process and ensuring that the equipment is functioning as expected.
  • Quality Control (QC) Team: Responsible for verifying particle size readings and ensuring they fall within the specified range as outlined in the BMR or product specifications.
  • Maintenance Team: Responsible for ensuring that the inline particle size monitoring equipment is calibrated, maintained, and functioning
properly during production.
  • Laboratory Supervisor: Responsible for overseeing the particle size monitoring process, reviewing data, and ensuring compliance with this SOP.
  • 4. Accountability

    The Production Manager is accountable for ensuring that inline particle size monitoring is performed as outlined in this SOP. The QC Manager is responsible for verifying the particle size readings and ensuring product quality. The Laboratory Supervisor is accountable for reviewing the particle size data and approving the process before moving to the next stage.

    5. Procedure

    5.1 Pre-Production Setup

    1. Ensure that the inline particle size monitoring system is properly calibrated and verified before the start of production. Calibration should be done according to the manufacturer’s guidelines and frequency outlined in the BMR.
    2. Ensure that all monitoring equipment, including sensors and probes, are in good working condition and properly installed at the appropriate points in the production line (e.g., after homogenization).
    3. Verify that the cream formulation is prepared according to the recipe, and all raw materials are properly mixed before inline particle size monitoring begins.
    4. Ensure that the required particle size range for the cream product is defined in the BMR or product specifications.

    5.2 Inline Particle Size Monitoring

    1. Monitor particle size in real-time during the cream production process by using the inline particle size monitoring system.
    2. The system should continuously measure particle size at defined intervals, typically every 10-15 minutes, depending on the batch size and production speed.
    3. Ensure that the particle size readings are continuously displayed and recorded. The particle size should fall within the specified range set in the BMR or product specifications.
    4. In case of automated monitoring, ensure that the system is set to trigger an alert if the particle size deviates from the acceptable range. The alert should notify the operator to take corrective action.

    5.3 Handling Deviations

    1. If the inline particle size readings fall outside the acceptable range, immediately notify the production team and take corrective actions as per the deviation procedure.
    2. Investigate the cause of the deviation, which could include issues such as improper mixing, equipment malfunction, or incorrect ingredient proportions.
    3. Once the issue is identified, take corrective actions, such as adjusting the homogenizer settings, modifying ingredient proportions, or reworking the batch if necessary.
    4. Document the deviation and corrective actions in the Deviation Report (Annexure-1), and ensure the report is reviewed by the QC and Laboratory Supervisors.

    5.4 Post-Monitoring Activities

    1. After completing the particle size monitoring, ensure that the product meets all required specifications before moving to the next production stage (e.g., filling or packaging).
    2. If the particle size is within the acceptable range, approve the batch for the next stage in the production process.
    3. If the particle size deviates from the acceptable range, reject the batch or initiate rework according to the Batch Rework SOP (SOP/CRM/004/2025).

    5.5 Documentation and Record-Keeping

    1. Record all particle size measurements in the Inline Particle Size Monitoring Log (Annexure-2). Ensure that the logs include the time, readings, and any corrective actions taken.
    2. Document any deviations and corrective actions in the Deviation Report (Annexure-1), ensuring that the report is signed by the operator and reviewed by the Laboratory Supervisor.
    3. Ensure that all records are securely stored and maintained for a minimum of two years or as required by regulatory guidelines.
    4. Review all records periodically for accuracy and compliance with product specifications.

    6. Abbreviations

    • GMP: Good Manufacturing Practices
    • QC: Quality Control
    • QA: Quality Assurance
    • BMR: Batch Manufacturing Record
    • PPE: Personal Protective Equipment
    • μm: Micrometer (unit of particle size)

    7. Documents

    1. Annexure-1: Deviation Report
    2. Annexure-2: Inline Particle Size Monitoring Log

    8. References

    • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
    • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • FDA Guidance for Industry: Particle Size Monitoring in Cream Manufacturing

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Deviation Report

    Batch Number Deviation Description Corrective Action Resolved By
    12345 Particle size outside range Adjusted homogenizer settings Jane Smith

    Annexure-2: Inline Particle Size Monitoring Log

    Batch Number Time Particle Size (μm) Operator Remarks
    12345 10:00 AM 5 μm John Doe Within specification

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/03/2024 1.0 Initial Version New SOP Creation QA Head
    01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
    See also  Creams: SOP for Line Clearance in Manufacturing Areas - V 2.0
    Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

    Post navigation

    Previous Post: Gel Manufacturing: SOP for Cleaning Filling Machines Post Gel Filling – V 2.0
    Next Post: API Manufacturing: SOP for Monthly Verification of QC Working Standards – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version